PRMT1 and hepatocellular carcinoma: FBXO7-mediated degradation of PRMT1 prevents PHGDH methylation and activation, thereby inhibiting serine synthesis, aggravating oxidative stress, and suppressing HCC growth in vitro and in vivo (Fig. 7m).